학술논문

Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer - Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 20 April 2024, 42(12):1450-1453)
Subject
Language
English
ISSN
15277755
0732183X